Zenith Spiral-Z G55236Recalls & reported problems
Cook Incorporated · Zenith, Spiral-Z AAA Iliac Leg · Class 3 · Implant
All models of Zenith Spiral-Z (29)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 10827002552361), received between Feb 1, 2024 and Jan 9, 2025 — classified as 3 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Fluid/Blood Leak” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Fluid/Blood Leak3
- Adverse Event Without Identified Device or Use Problem1
- Device Endoleak1
- Difficult or Delayed Activation1
Patient problems
- Clinical Endoleak3
- No Clinical Signs, Symptoms or Conditions1
- Paresthesia1
- Stenosis1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryJan 9, 2025Fluid/Blood Leak; Device Endoleak; Fluid/Blood Leak; Device Endoleak
IT WAS REPORTED THAT A TYPE 1B ENDOLEAK WAS IDENTIFIED ON THE LEFT ZENITH FLEX WITH SPIRAL-Z TECHNOLOGY AAA ENDOVASCULAR GRAFT ILIAC LEG DURING A FENESTRATED ENDOVASCULAR ABDOMINAL AORTIC ANEURYSM REPAIR (FEVAR) PROCEDURE ON A 67-YEAR-OLD MALE PATIENT. PRE-PROCEDURE IMAGING WAS COMPLETED ON (B)(6)2024, 112 DAYS PRIOR TO THE PROCEDURE. THE PROXIMAL SEALING ZONE DID NOT HAVE ANY OCCLUSIVE DISEASE OR CALCIFICATION. THROMBUS WAS NOT PRESENT IN THE PROXIMAL SEALING ZONE. THE PROXIMAL SEALING ZONE WAS DESCRIBED AS PARALLEL. THE RIGHT COMMON ILIAC ARTERY, LEFT COMMON ILIAC ARTERY, RIGHT EXTERNAL ILIAC ARTERY, LEFT EXTERNAL ILIAC ARTERY, RIGHT FEMORAL ARTERY, LEFT FORMAL ARTERY DID NOT HAVE ANY CALCIFICATION OR OCCLUSIVE DISEASE. THE ILIAC ARTERIES WERE NOT TORTUOUS. THE AORTA DIAMETER AT THE LOCATION OF THE MAXIMUM ANEURYSM DIAMETER (OUTER-WALL TO OUTER-WALL) WAS 63 MM. THE LENGTH OF THE SUITABLE PROXIMAL SEAL ZONE WAS 50 MM. THE DIAMETER OF THE AORTA AT LOCATION OF MAXIMUM DIAMETER OVER LENGTH OF PROXIMAL SEAL ZONE (OUTER-WALL TO OUTER-WALL) WAS 26 MM. THE DIAMETER OF AORTA AT THE LOCATION OF MINIMUM DIAMETER OVER LENGTH OF PROXIMAL SEAL ZONE (OUTER-WALL TO OUTER-WALL) WAS 24 MM. THE % C
Patient problems: Clinical Endoleak
MAUDE report 21111560 ↗MalfunctionDec 3, 2024Fluid/Blood Leak; Fluid/Blood Leak
NO ADDITIONAL INFORMATION REGARDING PATIENT AND/OR EVENT DETAILS HAS BEEN RECEIVED SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.
Patient problems: Clinical Endoleak
MAUDE report 20834036 ↗InjuryJul 12, 2024Fluid/Blood Leak; Fluid/Blood Leak
COOK WAS NOTIFIED OF A TYPE 3A ENDOLEAK ON A ZENITH FLEX WITH SPIRAL-Z TECHNOLOGY AAA ENDOVASCULAR GRAFT ILIAC LEG. THE 78-YEAR-OLD MALE UNDERWENT ENDOVASCULAR AORTIC REPAIR (EVAR) ON (B)(6) 2013 WHERE THE FOLLOWING COOK GRAFTS WERE PLACED: ZENITH LOW PROFILE AAA ENDOVASCULAR GRAFT MAIN BODY (RPN: ZALB-30-84); ZENITH FLEX WITH SPIRAL-Z TECHNOLOGY AAA ENDOVASCULAR GRAFT ILIAC LEG (ZSLE-16-39-ZT); ZENITH FLEX WITH SPIRAL-Z TECHNOLOGY AAA ENDOVASCULAR GRAFT ILIAC LEG (ZSLE-20-90-ZT); ZENITH BRANCH ENDOVASCULAR GRAFT ILIAC BIFURCATION (RPN: ZBIS-12-45-41). UPON REVIEW OF THE COMPUTED TOMOGRAPHY (CT) IT WAS DETERMINED THAT THERE WAS A TYPE 3A ENDOLEAK ON THE PATIENT'S RIGHT SIDE BETWEEN THE ZENITH FLEX WITH SPIRAL-Z TECHNOLOGY AAA ENDOVASCULAR GRAFT ILIAC LEG (ZSLE-16-39-ZT) AND THE ZENITH BRANCH ENDOVASCULAR GRAFT ILIAC BIFURCATION (RPN: ZBIS-12-45-41). IT WAS REPORTED THAT THE ZENITH FLEX WITH SPIRAL-Z TECHNOLOGY AAA ENDOVASCULAR GRAFT ILIAC LEG (ZSLE-16-39-ZT) MAY REQUIRE RELINING. ADDITIONAL INFORMATION REGARDING THE EVENT AND PATIENT OUTCOME HAS BEEN REQUESTED BUT IS CURRENTLY UNAVAILABLE.
Patient problems: Clinical Endoleak
MAUDE report 19732059 ↗MalfunctionMay 2, 2024Difficult or Delayed Activation; Difficult or Delayed Activation
ADDITIONAL INFORMATION WAS RECEIVED ON (B)(6) 2024. IT WAS REPORTED THAT ON THE RIGHT SIDE, DUE TO POOR DISTAL LANDING ZONE (LONG AND TORTUOUS WITH A LARGE DIAMETER OF 24MM) IN THE COMMON ILIAC ARTERY (CIA), A BRANCHED ILIAC GRAFT WAS PLANNED. HOWEVER, TO ACCELERATE THE PROCEDURE, IT WAS DECIDED INTRAOPERATIVELY TO USE A 28MM X 80MM GRAFT TO ACHIEVE A STABLE LANDING ZONE DESPITE THE SIZE OF THE CIA.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19234435 ↗InjuryFeb 1, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A STUDY PATIENT REQUIRED A SURGICAL FEMORAL ENDARTERECTOMY FOR "MOBILISATION OF FEMORAL PLAQUES" AFTER THE PLACEMENT OF COOK DEVICES ON (B)(6) 2023. THE PATIENT WAS 62 YEARS OLD AT THE TIME OF THE CUSTOM-MADE DEVICE PROCEDURE. HE HAD BEEN DIAGNOSED WITH HYPERTENSION AND HAD HISTORY OF OPEN ABDOMINAL SURGERY. THE PATIENTS JUXTARENAL AORTIC NECK MEASURED (<10 MM). HIS ABDOMINAL AORTIC ANEURYSM (AAA) HAD A HISTORY OF GROWTH GREATER THAN OR EQUAL TO 1.0 CM/YEAR. NO REPAIR PROCEDURES HAD BEEN COMPLETED AFTER THE PRIOR ENDOVASCULAR AORTIC REPAIR (EVAR). PRE-PROCEDURE IMAGING USING CONTRAST WAS COMPLETED ON (B)(6) 2023. THE INNOMINATE ARTERY, RIGHT COMMON CAROTID ARTERY, RIGHT SUBCLAVIAN ARTERY, LEFT COMMON CAROTID ARTERY, LEFT SUBCLAVIAN ARTERY, CELIAC ARTERY WERE ALL PATENT AND NO STENOSIS GREATER THAN 50% WAS IDENTIFIED. THE SUPERIOR MESENTERIC ARTERY WAS PATENT AND NO STENOSIS GREATER THAN 50% WAS IDENTIFIED. THE RIGHT RENAL ARTERY WAS PATENT AND NO STENOSIS GREATER THAN 50% WAS IDENTIFIED. THE LEFT RENAL ARTERY WAS PATENT AND NO STENOSIS GREATER THAN 50% WAS IDENTIFIED. THE RIGHT ACCESSORY RENAL ARTERY WAS PATENT AND NO NO STENOSIS GREATER THAN 50% WAS IDENTIFIED
Patient problems: Paresthesia; Stenosis
MAUDE report 18625994 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page